doi: 10.3390/ijms13033145
Br J Nutr (2013) 109:19908
3 Emerging challenges and nanoparticle vaccine platforms Although the advancement of nanovaccine technologies has brought remarkable progress in preventing infectious, inflammatory, allergic, and malignant diseases, several obstacles continue to impede their full clinical translation
Once the Trp residue is oxidized, the peptide no longer matches its intended sequence and loses biological activity
Figure 9 Neuroinflammation PET imaging has displayed elevated cytokines in the spinal cord and brain (46, 354), as well as increased activation of astrocytes (46, 354) and microglia (46, 47, 354)
Zeraatkar D, Johnston BC, Bartoszko J, Cheung K, Bala MM, Valli C, Rabassa M, Sit D, Milio K, Sadeghirad B, et al